AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Strensiq (asfotase alfa) — US product sales by Year
Strensiq (asfotase alfa) — US product sales ($M) ($M)
AstraZeneca Strensiq (asfotase alfa) — US product sales: $1,332M in FY2025, up 14.1% from a year earlier.
Where the FY2025 figure comes from
“|| Strensiq | 1,678 | 19 | 18 | 1,332 | 14 | 104 | 94 | 84 | 123 | 25 | 21 | 119 | 23 | 23”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Strensiq (asfotase alfa) — US product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,332 | +14.1% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 1,167 | +24.5% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 937 | +21.8% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 769 | +158.9% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 297 | – | Form 6-K FY2021Q4 Earnings Release ↗ |
Breakdown
What makes up strensiq (asfotase alfa) — US product sales
Cite this data
StockData. (2026). AstraZeneca Strensiq (asfotase alfa) — US product sales ($M), annual FY2021–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-strensiq-us
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.